|
Sanatate
|
|
Luni, 08 Aprilie 2024 09:24 |
|
It may not be to everyone's taste, but kombucha tea may be able to deliver the benefits of fasting, without the hardest part – the fasting itself. Researchers found that when the yeasts and bacteria from the fermented, sweetened tea colonized the gut, they altered fat metabolism, without any other dietary changes, resulting in lower fat stores.
At the center of these findings is the flora found in kombucha tea's SCOBY (Symbiotic Cultures of Bacteria and Yeasts), the gelatinous starter, rich in microbes, found floating near the surface of the fermented liquid. The probiotic microbes, including species of Acetobacter, Lactobacillus and Komagataeibacter genera, have previously been linked to a range of positive health benefits including lowering blood pressure.
|
|
Citeşte mai mult...
|
|
|
Sanatate
|
|
Luni, 18 Martie 2024 12:22 |
|
10 zile de tratament intensiv pentru hidratare.
Creșterea elasticității pielii și diminuarea ridurilor.
- Ser tratament bogat în SOD, supranumit „Superenzima Antiîmbătrânirii” și Acid Hialuronic pur şi lipozomal
- Liniile fine şi ridurile sunt vizibil reduse și umplute din interior
- Efect de regenerare și antioxidare
- Reduce adâncimea ridurilor profunde cu până la 26%*
- Nivelul de hidratare crește cu până la 67%***Eficacitate demonstrată prin evaluare instrumentală, după 28 de zile de utilizare **Eficacitate demonstrată prin evaluare instrumentală, după o oră de la prima aplicare
|
|
Citeşte mai mult...
|
|
Sanatate
|
|
Luni, 19 Februarie 2024 18:17 |
|
Folosind un jet de plasmă rece pentru a activa hidrogelul, cercetătorii au creat un pansament cu proprietăți antibacteriene și de vindecare a rănilor. Tehnologia ar putea fi folosită ca alternativă la tratamentele actuale care se bazează pe antibiotice pentru a trata rănile cronice, cum ar fi ulcerul piciorului diabetic.
The growing global number of diabetics means that there will be more people who experience a foot ulcer in their lifetime. For 60% of diabetics, these ulcers will become infected, and because of poor wound healing associated with the condition, the ulcers often become chronic wounds.
|
|
Citeşte mai mult...
|
|
Sanatate
|
|
Joi, 08 Februarie 2024 19:34 |
|
Researchers have used off-the-shelf components to create a sensor device that is not only cost-effective but can quickly detect 32 different pathogens and has sensitivities on par with the state-of-the-art biosensors used in pathology labs. The novel device could have a range of applications, from monitoring the effectiveness of cancer therapies to predicting the course of viral illnesses.
Diagnosing diseases early benefits patients and doctors. It enables treatment to slow disease progression and reduces the risk of complications, thereby improving long-term health outcomes. With early diagnosis in front of mind, a team from Helmholtz-Zentrum Dresden-Rossendorf (HZDR) research laboratory in Germany has used off-the-shelf components to construct a cost-effective, palm-sized device that can detect 32 different pathogens simultaneously.
|
|
Citeşte mai mult...
|
|
Sanatate
|
|
Joi, 04 Ianuarie 2024 13:12 |
|
Researchers have taken a big step forward in the quest to regenerate the pancreatic beta-cells damaged by type 1 diabetes. Using FDA-approved drugs usually given to patients with rare cancers, they reprogrammed pancreatic cells to produce and secrete insulin in response to glucose. The discovery could mean that, one day, diabetics won't need to take multiple daily insulin injections.
Pancreatic beta-cells synthesize, store and release insulin. But, in type 1 diabetes (T1D), the immune system selectively destroys these cells over time, leading to a lifelong dependence on exogenous insulin administration for survival. While insulin therapy helps control blood glucose, it doesn’t prevent, stop, or reverse the destruction of the pancreas’ insulin-secreting cells.
For many years, research has focused on identifying novel therapies that stimulate beta-cell growth and function to restore insulin production in type 1 diabetics. Now, in an exciting breakthrough, researchers at the Baker Heart and Diabetes Institute in Melbourne, Australia, have brought us a step closer to making this a reality, regenerating damaged pancreatic cells so they can produce insulin and functionally respond to blood glucose levels.
“We consider this regenerative approach an important advance towards clinical development,” said Sam El-Osta, the study’s corresponding author. “Until now, the regenerative process has been incidental and lacking confirmation; more importantly, the epigenetic mechanisms that govern such regeneration in humans remains poorly understood.”
The study builds upon previous proof-of-concept research by Baker Institute scientists, where they used an EZH2 inhibitor with a naturally derived drug to stimulate ductal progenitor cells, descendants of stem cells, into beta-like cells capable of producing insulin. Ductal cells are exocrine cells that form the lining of the tubes (ducts) that deliver pancreatic enzymes.
|
|
Citeşte mai mult...
|
|
|
|
|
|
|
Pagina 1 din 60 |
